Hansoh Pharmaceutical Group Co (HKSE:03692) Other Long-Term Liabilities : HK$303 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Other Long-Term Liabilities?

Hansoh Pharmaceutical Group Co's other long-term liabilities for the quarter that ended in Dec. 2023 was HK$303 Mil.

Hansoh Pharmaceutical Group Co's quarterly other long-term liabilities declined from Dec. 2022 (HK$417 Mil) to Jun. 2023 (HK$303 Mil) but then increased from Jun. 2023 (HK$303 Mil) to Dec. 2023 (HK$303 Mil).

Hansoh Pharmaceutical Group Co's annual other long-term liabilities increased from Dec. 2021 (HK$355 Mil) to Dec. 2022 (HK$417 Mil) but then declined from Dec. 2022 (HK$417 Mil) to Dec. 2023 (HK$303 Mil).

Hansoh Pharmaceutical Group Co Other Long-Term Liabilities Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Other Long-Term Liabilities Chart

Hansoh Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Hansoh Pharmaceutical Group Co Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial									-	-	-	-	-

Hansoh Pharmaceutical Group Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Hansoh Pharmaceutical Group Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

3KY:Germany

Address

287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210

Website

https://www.hspharm.com

Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines